KR950000141A - 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도 - Google Patents

피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도 Download PDF

Info

Publication number
KR950000141A
KR950000141A KR1019940012266A KR19940012266A KR950000141A KR 950000141 A KR950000141 A KR 950000141A KR 1019940012266 A KR1019940012266 A KR 1019940012266A KR 19940012266 A KR19940012266 A KR 19940012266A KR 950000141 A KR950000141 A KR 950000141A
Authority
KR
South Korea
Prior art keywords
acid
pharmaceutical composition
carnitine
composition according
ester
Prior art date
Application number
KR1019940012266A
Other languages
English (en)
Inventor
클라우디오 카바자
파올로 카바자
Original Assignee
알도 파시
아방가르드 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알도 파시, 아방가르드 에스.피.에이. filed Critical 알도 파시
Publication of KR950000141A publication Critical patent/KR950000141A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

본 발명은 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 L-카르니틴 O-에스테르의 용도에 관한 것으로서, 더욱 상세하게는 국소투여에 적합한 약제조성물 제조를 위한 활성성분으로서의 다음 구조식(Ⅰ)로 표시되는 에스테르 화합물의 용도에 관한 것이다.
상기식에서, R은 방향족산의 아실그룹이고, X-는 약제학적으로 수용할 수 있는 산의 음이온이다.

Description

피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 L-카르니틴 O-에스테르 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 피부병 치료의 국소투여에 적합한 약제조성물 제조를 위한 다음 구조식(Ⅰ)로 표시되는 방향족산을 함유한 L-카르니틴 에스테르의 용도.
    상기식에서, R은 살리실산, 아세틸살리실산, 니코틴산 및 트리메톡시벤조산 중에서 선택된 방향족산의 아실그룹이고, X-는 약제학적으로 수용할 수 있는 산의 음이온이다.
  2. 제1항에 있어서, 상기 구조식(Ⅰ)로 표시되는 L-카르니틴 에스테르는 분자내 염의 형태인 것을 특징으로 하는 방향족산을 함유한 L-카르니틴 에스테르의 용도.
  3. 제1항에 있어서, 상기 X-는 염화물, 브롬화물, 오로트산염, 아스파르트산염의 산, 시트라산염의 산, 인산염의 산, 푸마르산염, 푸마르산염의 산, 락트산염, 말레산염, 말레산염의 산, 옥살산염의 산, 황산염의 산, 글루코스 인산염, 타르타르산염 및 타르타르산염의 산 중에서 선택되는 것을 특징으로 하는 방향족산을 함유한 L-카르니틴 에스테르의 용도.
  4. 다음 구조식(Ⅰ)로 표시되는 L-카르니틴 에스테르 O-에스테르 및 약제학적으로 수용할 수 있는 부형제로 구성되어 있는 피부병 치료의 국소투여에 적합한 약제조성물.
    상기식에서, R 및 X'는 상기 제1항에서 정의한 바와 같다.
  5. 제4항에 있어서, 상기 약제조성물은 어린선 및 건선의 치료에 사용되는 것을 특징으로 하는 약제조성물.
  6. 제4항에 있어서, 상기 약제조성물은 각화 결손에 의한 피부병 치료에 사용되는 것을 특징으로 하는 약제조성물.
  7. 제6항에 있어서, 상기 피부병은 비듬, 여드름, 손바닥 과각화증 또는 발바닥 과각화증인 것을 특징으로 하는 약제조성물.
  8. 제4항에 있어서, 상기 약제조성물은 용액, 로션, 연고 또는 크림 형태임을 특징으로 하는 약제조성물.
  9. 제4항에 있어서, 상기 약제조성물은 상기 구조식(Ⅰ)로 표시되는 L-카르니틴 에스테르 O-에스테르 화합물 중에서 선택된 1종 이상의 것을 0.01~20중량% 함유하는 것을 특징으로 하는 약제조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940012266A 1993-06-02 1994-06-01 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도 KR950000141A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM93A000365 1993-06-02
ITRM930365A IT1261696B (it) 1993-06-02 1993-06-02 Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (1)

Publication Number Publication Date
KR950000141A true KR950000141A (ko) 1995-01-03

Family

ID=11401791

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940012266A KR950000141A (ko) 1993-06-02 1994-06-01 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도

Country Status (12)

Country Link
US (1) US5639767A (ko)
EP (1) EP0628308B1 (ko)
JP (1) JPH07309820A (ko)
KR (1) KR950000141A (ko)
AT (1) ATE174216T1 (ko)
CA (1) CA2124748A1 (ko)
DE (1) DE69415081T2 (ko)
DK (1) DK0628308T3 (ko)
ES (1) ES2126674T3 (ko)
GR (1) GR3029536T3 (ko)
IT (1) IT1261696B (ko)
ZA (1) ZA943808B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100783145B1 (ko) * 2002-04-23 2007-12-07 삼성광주전자 주식회사 선회형 흡입구를 가지는 청소 로봇

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10133200A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
ITRM20020055A1 (it) * 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
CN107540605B (zh) * 2016-12-28 2020-03-06 宁波见睿新材料有限公司 用于头发或头皮护理的胆碱酯类化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2354769A1 (fr) * 1976-06-15 1978-01-13 Tanabe Seiyaku Co Derives de nicotinoylcarnitines, leur preparation et leurs utilisations therapeutiques
CH679856A5 (ko) * 1990-07-04 1992-04-30 Lonza Ag

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100783145B1 (ko) * 2002-04-23 2007-12-07 삼성광주전자 주식회사 선회형 흡입구를 가지는 청소 로봇

Also Published As

Publication number Publication date
ITRM930365A1 (it) 1994-12-02
IT1261696B (it) 1996-05-29
DE69415081T2 (de) 1999-04-29
GR3029536T3 (en) 1999-06-30
ATE174216T1 (de) 1998-12-15
EP0628308B1 (en) 1998-12-09
DK0628308T3 (da) 1999-08-16
US5639767A (en) 1997-06-17
JPH07309820A (ja) 1995-11-28
ITRM930365A0 (it) 1993-06-02
DE69415081D1 (de) 1999-01-21
CA2124748A1 (en) 1994-12-03
EP0628308A1 (en) 1994-12-14
ES2126674T3 (es) 1999-04-01
ZA943808B (en) 1995-01-30

Similar Documents

Publication Publication Date Title
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
US4363815A (en) Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
DE69417290T2 (de) Verwendung von L-Carnitin-O-Estern zur Behandlung der Dermatosen
ES2040242T3 (es) Composiciones farmaceuticas.
US5019567A (en) Benzoyl peroxide--quaternary ammonium lipophilic salicylate based pharmaceutical and cosmetic compositions and their use especially in treatment of acne
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
KR950000141A (ko) 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도
JP3831431B2 (ja) L−カルニチン塩および化粧用および皮膚病処置用医薬組成物
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
CA2147808C (fr) Composes bi-aromatiques acetylenes a groupement adamantyle, compositions pharmaceutiques et cosmetiques les contenant et utilisations
CA2362343C (en) Method and composition for treating acne
EP0024096B1 (en) Complexes of bivalent copper, methods of preparation thereof and compositions containing said complexes
JPH08301760A (ja) 皮膚外用剤
DE69111974T2 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
DE69503724T2 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
PT90356A (pt) Processo para a preparacao de composicoes farmaceuticas contendo solucoes aquosas de pentamidina
DE4415204A1 (de) Neue Retinol (Vitamin A) -Derivate, deren Herstellung und Verwendung als Arzneimittel und Kosmetika
US6827943B2 (en) Dermatological composition containing urea
NZ205587A (en) Composition comprising undecylenic acid for treating herpes simplex i
DE60032114T2 (de) Behandlungsmethode von aknepatienten durch verabreichung von hemmern der cyclischen gmp pde
JPH0328402B2 (ko)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid